A Larkin Township man was arraigned in Midland County District Court on Friday on a felonious assault charge stemming from New Year’s Eve afternoon. Carson Beins, 42, is lodged in the Midland County ...

Arbutus Biopharma ( (ABUS)) has issued an announcement. On December 11, 2025, Lindsay Androski, CEO of Arbutus Biopharma, presented at Roivant Sciences Ltd.’s Investor Day regarding ongoing lawsuits ...

WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Thursday reported a loss of $7.7 million in its third quarter. The Warminster, Pennsylvania-based company said it had a ...

Trailing-edge dimmers offer smoother, quieter control for modern lighting systems—but their inner workings often remain overlooked. This post sheds light on the circuitry behind the silence. Sometimes ...

The character backgrounds in The Outer Worlds 2 are more important than you think. Although this decision won’t make or break your game, it can help you role-play as a trigger-happy maniac, annoying ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

Forbes contributors publish independent expert analyses and insights. William Arruda covers personal branding, leadership, and careers. These above-the-fold elements pretty much all people see when ...

WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Wednesday reported second-quarter net income of $2.5 million, after reporting a loss in the same period a year earlier.

Arbutus Biopharma had made no secret of its plans to step up its work on imdusiran. Now, the company has regained the China rights to the potential functional cure for hepatitis B. China-based Qilu ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The end of the deal, which ...

WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Wednesday reported a loss of $24.5 million in its first quarter. On a per-share basis, the Warminster, ...